|
|
|
|
 |
Corporate Profile
Æterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a late-stage drug development company specialized in oncology and endocrinology.
Contact us:
Æterna Zentaris Inc.
1405 du Parc-Technologique Blvd.
Québec, Québec
Canada
G1P 4P5
Phone: (418) 652-8525
Fax: (418) 652-0881
www.aezsinc.com
|
 |
|
|
Aeterna Zentaris Reports Second Quarter 2010 Financial and Operating Results more...>
Aeterna Zentaris Announces NIH Grant for a Phase 1/2 Study in Advanced Prostate Cancer with AEZS-108 more...>
Aeterna Zentaris to Announce Second Quarter 2010 Financial and Operating Results on August 12, 2010 more...>
Aeterna Zentaris to Present at Upcoming Canaccord Genuity 30th Annual Growth Conference 2010 on August 12 more...>
Aeterna Zentaris Announces Perifosine Has Received
Orphan-Drug Designation for the Treatment of Neuroblastoma more...>
|
 |
|
June 10, 2010
9th Annual Needham Healthcare Conference
More |
|
|
Download PDF (67K) |
| Download and install Acrobat Reader 6.0. |
|
|
|
